Πηγαίνετε εκτός σύνδεσης με την εφαρμογή Player FM !
Highlights in breast cancer from ESMO 2023
Manage episode 384282004 series 2424442
The European Society for Medical Oncology (ESMO) Congress 2023, which took place in Madrid, Spain, gathered internationally acclaimed experts to share and deliberate on the most recent breakthroughs in oncology. In this podcast, we listen to prominent healthcare professionals offering a summary of key moments from this year’s conference.
Today we are joined by Peter Schmid (Barts Cancer Institute, London, UK), Erika Hamilton (Sarah Cannon Research Institute, Nashville, TN), Kevin Kalinsky (Emory University Hospital, Atlanta, GA), and Sherene Loi (Peter MacCallum Cancer Centre, Victoria, Australia), who share key updates in breast cancer at ESMO 2023. Topics discussed include findings from the BEGONIA (NCT03742102), KEYNOTE-522 (NCT03036488), CheckMate7FL trials (NCT04109066), novel estrogen receptor degraders vepdegestrant, as well the current state of CDK4/6 inhibitors in metastatic HER2-negative breast cancer.
The post Highlights in breast cancer from ESMO 2023 appeared first on VJOncology.
179 επεισόδια
Manage episode 384282004 series 2424442
The European Society for Medical Oncology (ESMO) Congress 2023, which took place in Madrid, Spain, gathered internationally acclaimed experts to share and deliberate on the most recent breakthroughs in oncology. In this podcast, we listen to prominent healthcare professionals offering a summary of key moments from this year’s conference.
Today we are joined by Peter Schmid (Barts Cancer Institute, London, UK), Erika Hamilton (Sarah Cannon Research Institute, Nashville, TN), Kevin Kalinsky (Emory University Hospital, Atlanta, GA), and Sherene Loi (Peter MacCallum Cancer Centre, Victoria, Australia), who share key updates in breast cancer at ESMO 2023. Topics discussed include findings from the BEGONIA (NCT03742102), KEYNOTE-522 (NCT03036488), CheckMate7FL trials (NCT04109066), novel estrogen receptor degraders vepdegestrant, as well the current state of CDK4/6 inhibitors in metastatic HER2-negative breast cancer.
The post Highlights in breast cancer from ESMO 2023 appeared first on VJOncology.
179 επεισόδια
Minden epizód
×Καλώς ήλθατε στο Player FM!
Το FM Player σαρώνει τον ιστό για podcasts υψηλής ποιότητας για να απολαύσετε αυτή τη στιγμή. Είναι η καλύτερη εφαρμογή podcast και λειτουργεί σε Android, iPhone και στον ιστό. Εγγραφή για συγχρονισμό συνδρομών σε όλες τις συσκευές.